Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults
Clinical trial NCT05613205 · COMPLETED
Trial details
- NCT number
- NCT05613205
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-28
- Primary completion
- 2023-12-06
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.